针对基因组 lysine甲基化的表观遗传疗法:复杂的机制和临床挑战
The Journal of clinical investigation
|October 15, 2024
概括
向激素氨酸甲基化的表观遗传疗法正在进步,有新的FDA批准的药物和对激素氨酸甲基转移酶 (HKMT) 和脱甲基酶 (HKDM) 的持续研究. 未来的发展重点是复杂的破坏和基于癌症治疗的近距离策略.
科学领域:
- 生物化学 生物化学
- 分子生物学分子生物学
- 药理学 药理学是指药理学的学科.
背景情况:
- 针对基因组 lysine甲基化的表观遗传疗法是治疗癌症和其他疾病的不断增长的领域.
- 目前临床上可行的疗法仅限于向特定的素甲基转移酶 (HKMT) 和脱甲基酶 (HKDM),而tazemetostat (EZH2抑制剂) 已获得FDA批准.
研究的目的:
- 审查最近的临床和临床前研究关于素组合素甲基化向治疗的研究.
- 提供最新的治疗开发和分子理解在过去五年.
- 为了提供一个新的视角,超越"基因组密码"比喻,对基因组 lysine 甲基化.
主要方法:
- 审查最近的临床和临床前研究.
- 对HKMTs和HKDMs治疗开发的进展进行分析.
- 探索分子理解的基因素氨酸甲基化.
主要成果:
- 针对HKMT和HKDM的临床可行疗法的出现,包括EZH2,DOT1L,MLL1/COMPASS,LSD1,KDM5,KDM6和KDM2.
- 在了解这些点的分子机制和治疗潜力方面取得了重大进展.
- 确定当前治疗策略的局限性,主要是催化域抑制剂.
结论:
- 对于基因组 lysine 甲基化的表观遗传疗法领域正在迅速发展,随着新药的批准和不断扩大的研究.
- 未来的治疗开发可能会转向复杂破坏性抑制剂和基于近距离的方法.
- 对于细微的理解 基因组 lysine甲基化 对于开发更有效的治疗方法至关重要.
相关概念视频
Histone Modification
13.1K
The histone proteins have a flexible N-terminal tail extending out from the nucleosome. These histone tails are often subjected to post-translational modifications such as acetylation, methylation, phosphorylation, and ubiquitination. Particular combinations of these modifications form “histone codes” that influence the chromatin folding and tissue-specific gene expression.
Acetylation
The enzyme histone acetyltransferase adds acetyl group to the histones. Another enzyme, histone...
Acetylation
The enzyme histone acetyltransferase adds acetyl group to the histones. Another enzyme, histone...
13.1K
Epigenetic Regulation
3.0K
Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
X-chromosome...
3.0K
Spreading of Chromatin Modifications
8.2K
The histone proteins in the nucleosomes are post-translationally modified (PTM) to increase or decrease access to DNA. The commonly observed PTMs are methylation, acetylation, phosphorylation, and ubiquitination of lysine amino acids in the histone H3 tail region. These histone modifications have specific meaning for the cell. Hence, they are called "histone code". The protein complex involved in histone modification is termed as "reader-writer" complex.
Writers
The writer...
Writers
The writer...
8.2K
Chromatin Modification in iPS Cells
1.6K
Chromatin modification alters gene expression; therefore, scientists can add histone-modifying enzymes, histone variants, and chromatin remodeling complexes to somatic cells to aid reprogramming into pluripotent stem (iPS) cells.
Compact chromatin makes reprogramming difficult. Enzymes, such as histone demethylases and acetyltransferases, are often added during reprogramming to loosen the chromatin, making the DNA more accessible to transcription factors. Molecules that inhibit histone...
Compact chromatin makes reprogramming difficult. Enzymes, such as histone demethylases and acetyltransferases, are often added during reprogramming to loosen the chromatin, making the DNA more accessible to transcription factors. Molecules that inhibit histone...
1.6K
Inheritance of Chromatin Structures
6.2K
Epigenetics is the study of inherited changes in a cell's phenotype without changing the DNA sequences. It provides a form of memory for the differential gene expression pattern to maintain cell lineage, position-effect variegation, dosage compensation, and maintenance of chromatin structures such as telomeres and centromeres. For example, the structure and location of the centromere on chromosomes are epigenetically inherited. Its functionality is not dictated or ensured by the underlying...
6.2K
Phase II Reactions: Methylation Reactions
149
Methylation is a phase II biotransformation process involving the attachment of a methyl group to a substrate. Enzymes known as methyltransferases orchestrate this reaction.
The mechanism of methylation unfolds in two stages. The first stage sees a methyltransferase enzyme facilitating the transfer of a methyl group from S-adenosylmethionine (SAM) to the substrate, forming S-adenosylhomocysteine (SAH). The second stage involves further metabolism of SAH into homocysteine, which can be recycled...
The mechanism of methylation unfolds in two stages. The first stage sees a methyltransferase enzyme facilitating the transfer of a methyl group from S-adenosylmethionine (SAM) to the substrate, forming S-adenosylhomocysteine (SAH). The second stage involves further metabolism of SAH into homocysteine, which can be recycled...
149


